Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Hospital tracks Staff's COVID antibodies for a year after vaccination

NCT ID NCT04939402

Summary

This study aims to understand how the immune system responds to the AstraZeneca COVID-19 vaccine over time. Researchers are tracking 200 hospital employees who received this vaccine, measuring their antibody levels at three points over a year. The goal is to see how long vaccine protection lasts and how well it prevents infections.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COVID19 are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • UZ Brussel

    Brussels, 1090, Belgium

Conditions

Explore the condition pages connected to this study.